Search Results for "Orthophoenix Llc Medtornic Kyphon Patents"

14:10 EDT 1st September 2015 | BioPortfolio

Matching Channels

Biosuperior Antibodies

After biosimilar versions of therapeutic proteins have become reality in Europe and in the US, now it’s the turn of therapeutic antibodies to be in the line of fire. Patents of the first wave of...

Tumor Necrosis Factor TNF Products

Tumor Necrosis Factor (TNF) and TNF receptor antagonists and agonists used to treat TNF-mediated inflammatory diseases such as rheumatoid arthritis or to treat cancer. TNF blockers are the commerc...

Coagulation Factors

Fourteen different blood coagulation factors are present in the body. Each plays a crucial role in the process described above. Some work to increase the activity level of the other factors while so...

Matching News

Suven secures three product patents for their NCEs in Canada, Japan and Korea

Biospectrum With these new patents, Suven has a total of 18 granted patents from Canada, 16 granted patents from Japan,...

Ocata gets three new US patents for RPE therapy for macular degenerative diseases

Ocata Therapeutics, a leader in the field of Regenerative Ophthalmology, announced that the US Patent and Trademark Office (USPTO) issued three new US Patents, Nos. 9,040,770, 9,040,039 and 9,040,038,...

Are Software Patents Dead?—Alice’s Implications for Life Sciences

Not too long ago, getting patents on software and business methods was all the rage. And concern about their effects was profound. In fact, in 2003 I spoke at a Federal Reserve Bank conference devoted...

BRIEF-Crossject announces five new patents

* All patents linked with optimization of Zeneo in the framework of the industrialization of this product

Suven Life Sciences granted new patents

Patents cover drugs for treating neurodegenerative disorders

Patents forecast technological change

(Massachusetts Institute of Technology) Engineers at MIT have devised a formula for estimating how fast a technology is advancing, based on information gleaned from relevant patents.

UPDATE 2-Hedge fund manager Kyle Bass loses challenges to pharma patents

NEW YORK, Aug 24 (Reuters) - Prominent hedge fund manager Kyle Bass's campaign to wipe out certain drug patents hit a roadblock on Monday when the U.S. Patent and Trademark Office declined to formally...

Patent challenges in five countries dispute validity of Gilead's claims to Sovaldi patents

Gilead Sciences is seeking illegitimate patents for hepatitis C medicine sofosbuvir, blocking millions…

Matching PubMed Articles

The importance of patents to innovation: updated cross-industry comparisons with biopharmaceuticals.

Patents have long been considered essential incentives to foster innovation, particularly the development of new prescription drugs, due to the lengthy, costly, and risky nature of the research and de...

Stem Cell Patents after the America Invents Act.

Under the newly passed Leahy-Smith America Invents Act (AIA), the U.S. Patent and Trademark Office may hear new challenges to stem cell patents. Here, we explore how the new law affects challenges to ...

Dendritic-cell-based technology landscape: Insights from patents and citation networks.

As the most potent antigen-presenting cells, dendritic cells (DCs) are pivotal players in regulating immune responses. DC-based technologies have generated a series of typical and promising therapeuti...

Newer patents in antimycobacterial therapy.

Tuberculosis caused by Mycobacterium tuberculosis is a global health emergency. This deadly disease has far-reaching social and economic implications. Diseased individuals need prolonged polypharmacy ...

Recent Patents on New Steroid Agents Targeting the Steroidogenesis for Endocrine Cancer Treatments.

Cancer is a leading cause of death in the population and despite the significant technological advances that have been made over the last years; there is a great need for new and better treatments wit...

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement